Search results

Ad hoc announcement pursuant to Art. 53 LR. medmix announces final offer price of CHF 45 per new medmix share, resulting in gross proceeds of CHF 315 million

COX Handheld Dispensers for One and Two-Component Materials: PC COX legacy since 1958 inherited by medmix Switzerland Ltd.

medmix' Drug Delivery (“Haselmeier”) and NIPRO CORPORATION (“Nipro”) announce an exclusive promotion and distribution partnership for PiccoJect™ in the Japanese market.

medmix, the global leader in high-precision delivery devices, is announcing its newly crafted sustainability policy. With a holistic approach that serves Planet, Profit and People, the policy will guide medmix towards its ambitious sustainability targets, ensuring that sustainability is reflected at all levels of the company.

As we celebrate the centennial anniversary of the MK brand (est. 1922) and its benefits of quality, reliability, and performance, medmix is now launching the first of a new generation of MK 1-component, manual dispensers with an improved look and feel, for long-lasting professional performance.

Established in 1922, MK™ develops innovative, high quality dispensers for sealant and adhesive materials, producing specialized and customized ranges of both single and dual-component dispensers.

Mixpac, a leading provider of high-precision delivery devices, has announced that it has joined the Adhesive and Sealant Council (ASC) as a new member. The ASC is a North American trade association dedicated to representing the adhesive and sealant industry, promoting knowledge sharing, and supporting future growth.

Ad hoc announcement pursuant to Art. 53 LR FULL YEAR 2021 HIGHLIGHTS

Ad hoc announcement pursuant to Art. 53 LR FULL YEAR 2022 HIGHLIGHTS

In line with its vision of creating a cleaner beauty industry, GEKA has been awarded a B Supplier Engagement Rating (SER) by the CDP for reducing the climate impact of its supply chain. The rating builds on an overall climate change score of B for GEKA in 2021, illustrating how the high precision beauty application expert is taking a leading role in sustainable cosmetics.

Ad hoc announcement pursuant to Art. 53 LR

Ad hoc announcement pursuant to Art. 53 LR medmix suspends the operations of its manufacturing site in Wroclaw, Poland as a result of sanctions levied by the Polish government. The sanctions apply to medmix’ minority shareholder, Viktor Vekselberg, but have been extended to medmix Poland, even though Mr. Vekselberg has no control or ownership of any medmix entities and is deprived of all his economic rights in medmix.

Ad hoc announcement pursuant to Art. 53 LR medmix announced today that Itee Satpathy is to succeed Friedrich von Gadow as Chief Human Resources Officer and member of the Executive Committee, effective December 1, 2021. Friedrich von Gadow is returning to Sulzer as he has been appointed as Head Human Resources for Switzerland.

medmix, a leading provider of high-precision liquid application and mixing technologies, has announced it is expanding with a new supply facility in Salem, New Hampshire. The site is part of medmix’ wider local for local strategy in the USA, designed to reduce lead times and increase the service level for customers at the industry and dental sectors.

In April 2023, a test program was performed to assess the compatibility of Nipro’s D2F™ pre-fillable syringes (“PFS”) with the PiccoJect 100 autoinjector from medmix. The test results confirm full compatibility of Nipro’s PFS with PiccoJect 100.

Ad hoc announcement pursuant to Art. 53 LR

The global market of hot melt adhesives is projected to grow substantially through 2029*. One of the main drivers will be increased demand for advanced consumer electronic products. With the new MIXPAC 30 mL purHT 1K cartridge kit from medmix, end-users will be able to significantly boost their bonding performance and meet this trend.

Ad hoc announcement pursuant to Art. 53 LR medmix is relocating production to other countries following an initial negative decision on sanctions unilaterally introduced by Poland. It is medmix’ firm belief that the sanctions against its entity in Poland are erroneous. The company continues its appeal process, with the full support of the Swiss government administration. medmix is not affected by any other sanctions and is free to develop its business globally.

medmix Drug Delivery introduces PiccoJect™, a disposable two-step autoinjector designed for subcutaneous injection. The device is being developed in two variants (PiccoJect™ 100 and PiccoJect™ 225) for a standard 1 ml long or 2.25 ml pre-filled glass or plastic syringes. With a focus on patient centric design and a commitment to sustainability, PiccoJect™ is composed of only eight parts and features an ergonomic shape and a large wrap-around drug window.

Ad hoc announcement pursuant to Art. 53 LR medmix announces negotiations for the sale of its Polish entity, following its decision to stop production in Wroclaw, Poland. The company revises its outlook for FY 2022, reflecting the impact of mitigating sanctions in Poland, ongoing inflationary pressures, and mix.

medmix, global leader in high-precision delivery devices, won the prestigious Good Design™ Award 2022 in the Medical category for PiccoJect™, the autoinjector from medmix Drug Delivery (Haselmeier™). PiccoJect™ is a disposable two-step autoinjector designed for subcutaneous injection.

At today’s annual general meeting (AGM) of medmix Ltd, shareholders approved all proposals of the Board of Directors. Rob ten Hoedt was newly elected as Chairman. medmix will pay an ordinary dividend of CHF 0.50 per share to shareholders.

medmix wins 2024 BIG Innovation Award for MIXPAC™ greenLine™ 400 mL 1:1 two-component cartridge set made from up to 100% recycled plastic.

medmix Drug Delivery (Haselmeier) launches its passive needle safety device SicuroJect™ at Pharmapack Europe in Paris, further expanding its product portfolio.

medmix, a global leader in high-precision delivery devices, announces the successful completion of its acquisition of China-based Guangdong Qiaoyi Plastic Co. Ltd., following the announcement made in January 2023. This acquisition allows medmix to rapidly expand its global Beauty footprint in Asia.